251 related articles for article (PubMed ID: 5710726)
1. [Sympatholytic ("antisympathotonic") substances].
Kruger K
Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
[No Abstract] [Full Text] [Related]
2. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
[No Abstract] [Full Text] [Related]
3. [The inherent contractility-reducing effect of various beta-adrenolytic agents on a heart-lung preparation in the dog].
Schmidt HD; Schmier J
Z Kreislaufforsch; 1967 Nov; 56(11):1137-50. PubMed ID: 5595876
[No Abstract] [Full Text] [Related]
4. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
Z Kreislaufforsch; 1967 Jul; 56(7):716-44. PubMed ID: 5592004
[No Abstract] [Full Text] [Related]
5. [Metabolic effects of various palliative drugs for coronary insufficiency].
Deltour G
Therapie; 1970; 25(2):293-322. PubMed ID: 4404034
[No Abstract] [Full Text] [Related]
6. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
Jageneau A; Schaper W
Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
[No Abstract] [Full Text] [Related]
7. [Effect of pharmacological substances on the blood supply and work of the heart].
Kisin IE
Kardiologiia; 1969 Jun; 9(6):143-9. PubMed ID: 4185160
[No Abstract] [Full Text] [Related]
8. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
Urbaszek W; Kalkowski H; Günther K; Splith G; Trenckmann H
Z Gesamte Inn Med; 1969 Feb; 24(4):102-8. PubMed ID: 4978753
[No Abstract] [Full Text] [Related]
9. [The relationship of cardiodepressive and adrenolytic effects of various beta-receptor blocking agents on dog heart-lung preparations].
Schmidt HD; Schmier J
Klin Wochenschr; 1967 Jul; 45(13):688-90. PubMed ID: 5589240
[No Abstract] [Full Text] [Related]
10. [Effect of beta-receptor blocking agents and related substances on the excitation, contraction and energy metabolism of myocardium fibers].
Fleckenstein A; Döring HJ; Kammermeier H
Klin Wochenschr; 1968 Apr; 46(7):343-51. PubMed ID: 4386795
[No Abstract] [Full Text] [Related]
11. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
Fleckenstein A; Tritthart H; Fleckenstein B; Herbst A; Grün G
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
[No Abstract] [Full Text] [Related]
12. [The coronary dilatator effect of various reference drugs].
Duchene-Marullaz P; Cosnier D; Grimald J
Therapie; 1969; 24(4):617-20. PubMed ID: 5821999
[No Abstract] [Full Text] [Related]
13. [Limitation of the disappearance of energy-rich phosphate compounds in the hyperactive atrial and ventricular myocardium by divalent Ca-antagonistic inhibitors of electromechanical coupling (iprovdratril, D 600, prenylamine)].
Doring HJ; Leder O; Jaedicke W; Reindell A; Fleckenstein A
Pflugers Arch; 1969; 312(1):R7-8. PubMed ID: 5390299
[No Abstract] [Full Text] [Related]
14. [The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].
Rudolph W; Kriener J; Meister W
Arzneimittelforschung; 1971 Apr; 21(4):462-5. PubMed ID: 5108271
[No Abstract] [Full Text] [Related]
15. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
Fleckenstein A; Tritthart H; Flackenstein B; Herbst A; Grün G
Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
[No Abstract] [Full Text] [Related]
16. [Separation of the divalent Ca++ antagonistic effect component from the beta-adrenolytic effects of cardio-depressive drugs on cultures of embryonic heart muscle cells].
Kaufmann R; Tritthart H; Rost B
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):252-3. PubMed ID: 4242400
[No Abstract] [Full Text] [Related]
17. Cardiovascular actions of iproveratril.
Ross G; Jorgensen CR
J Pharmacol Exp Ther; 1967 Dec; 158(3):504-9. PubMed ID: 6073232
[No Abstract] [Full Text] [Related]
18. [Parallel influence of isometric tension development and O2 consumption of isolated papillary muscles under the influence of Ca ions, adrenaline, isoproteranol and organic Ca antagonists (iproveratril, D 600, prenylamine)].
Byon KY; Fleckenstein A
Pflugers Arch; 1969; 312(1):R8-9. PubMed ID: 5390309
[No Abstract] [Full Text] [Related]
19. [Studies on the mechanism of action of INPEA, iproveratril and oxyfedrin].
Bosse JA; Schaum E
Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):221-2. PubMed ID: 4390696
[No Abstract] [Full Text] [Related]
20. [Comparative studies in the heart-lung-preparation of dog on the action spectrum of verapamil, quinidine and some alpha- and beta-sympatholytics as well as the effect of adrenaline].
Haas H; Igarashi T
Arzneimittelforschung; 1968 Nov; 18(11):1373-80. PubMed ID: 5755900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
